Confidently size your market and understand target patient populations using a single source of epidemiology intelligence, featuring a unique combination of incidence and prevalence literature review, in-depth disease-specific forecasts and U.S. claims-based insights.
Benchmark your forecasts with epidemiology data on the total potential and addressable market.
Validate your investments and identify growth opportunities using bottom-up forecasting.
Confidently estimate drug-treated populations and understand how populations will change over time.
High-level overview of 1200+ diseases, including niche and rare
Zero in to detailed population data and forecasts for 220+ larger diseases
countries covered, with extrapolated data extending to 126 regions
team of global expert epidemiologists